Profil
Cynthia Shumate has been Secretary, Chief Compliance Officer and Vice President-Legal Affairs of PDL BioPharma, Inc. since October 2006.
She was Vice President-Intellectual Property of PDL BioPharma from September 2006 to April 2004.
Previously, Ms. Shumate was Senior Director and Associate General Counsel, Intellectual Property at Corixa Corporation from 1998 to 2004.
.
Prior to Corixa, she was a Patent Attorney at Cell Therapeutics, Inc. from 1997 to 1998 and NeoRx Corporation from 1993 to 1997.
Ms. Shumate received a JD degree from The John Marshall Law School, Chicago and a Bachelor's degree in Biology from Western Washington University at Bellingham.
Anciens postes connus de Cynthia Shumate
| Sociétés | Poste | Fin |
|---|---|---|
| PDL BIOPHARMA, INC. | Conseiller Juridique Général | 01/01/2008 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 10/01/2006 |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Directeur/Membre du Conseil | 01/01/2005 |
| CTI BIOPHARMA CORP. | Conseiller Juridique Général | 01/01/1998 |
| PONIARD PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/01/1997 |
Formation de Cynthia Shumate
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
John Marshall Law School (Georgia)
John Marshall Law School (Georgia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Washington University
Western Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
















